跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HAT-2
首页
药物
HAT-2
HAT-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMBINATION OF SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR USE IN TREATING A HEMATOLOGICAL MALIGNANCY
EP 4048260 C0
申请人: CELGENE CORP
优先权: 2019
CN
EP
US
WO
9 件公开
Cancer Cell Apoptosis
US 2012190735 A1
申请人: YOUNG MALCOLM PHILIP
优先权: 2009
CN
US
3 件公开
NANOSPHERE- HISTONE ACETYLTRANSFERASE (HAT) ACTIVATOR COMPOSITION, PROCESS AND METHODS THEREOF
US 2015119466 A1
申请人: JNCASR BANGALORE
优先权: 2012
US
2 件公开
Preparation method and application of electrode material
CN 120665075 A
申请人: UNIV QUJING NORMAL
优先权: 2020
CN
2 件公开
Chicken interleukin-2-receptor alpha chain extracellular region protein monoclonal antibody, and its preparing method
CN 1850862 A
申请人: UNIV ZHEJIANG
优先权: 2006
CN
Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket
CN 101129353 B
申请人: BEIJING SHENOGEN PHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2007
CN
Medicine cap capable of treating encephalatrophy and manufacture method thereof
CN 101507856 A
申请人: LANGHUI LI
优先权: 2008
CN
Domestic self-service hair curling method
CN 101972076 A
申请人: GUANGZHOU YOUNGRACE COSMETICS CO LTD
优先权: 2010
CN
Medicine hat for treating seborrheic alopecia
CN 102068570 A
申请人: HUIZHOU OUYE TECHNOLOGY CO LTD
优先权: 2010
CN
CD138-resistant monoclonal antibody variable region sequence as well as preparation method and application thereof
CN 103103197 A
申请人: ABGENT BIOTECHNOLOGY SUZHOU CO LTD
优先权: 2013
CN
第 1 / 4 页
上一页
下一页
药物
反馈